by Don McLean | Jun 29, 2020 | Blog
Whitepaper: Pharmaceutical Industry Challenges Facing Clinical Trial Disclosure and Transparency By MMS Holdings and TrialAssure [Fill out the form below to access the whitepaper] While global regulatory authorities routinely update clinical trial disclosure and...
by Don McLean | Apr 16, 2020 | News
FORMER GILEAD SCIENCES HEAD OF CLINICAL TRIAL DISCLOSURE AND DATA TRANSPARENCY JOINS MMS AND TRIALASSURE AS DIRECTOR OF GLOBAL TRANSPARENCY STRATEGY AND COMPLIANCE CANTON, Mich. (April 16, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO –...
by Don McLean | Feb 7, 2020 | Blog
The New Roaring 20s: 12 Experts Provide Pharmaceutical Insights for the Decade Ahead by Aaron Robert The pharmaceutical industry—and healthcare in general—are in constant stages of innovation. According to the International Federation of Pharmaceutical Manufacturers...
by Don McLean | May 9, 2019 | Blog
FREE DOWNLOAD: Lay Summary Whitepaper This complimentary lay summary whitepaper will explain: the ins and outs of lay summary writing, the importance of starting a pilot program, a checklist for lay reviewers, and strategic advice for becoming more transparent....
by Don McLean | Mar 14, 2019 | Blog
PhUSE: Retrospective vs. Proactive Anonymization of Narratives Exerpt from whitepaper originally published by PhUSE on March 14, 2019 by project co-leads – Rashmi Dodia, MS, RAC and Gregory Campbell, BS Executive Summary Ever since policy 0070 was first introduced in...
